Skip to content
The Nexus
DossierENTITY

Rahul Gosain

Coverage of Rahul Gosain in the Nexus archive.

Earliest in view: Jun 30 · 20:47 UTCMost recent: Jun 30 · 20:47 UTC
Co-mentioned in this coverage
GLP-1 receptor agoniststopic1Ozempictopic1breast cancertopic1colorectal cancertopic1Endometrial cancertopic1Penn Medicineorganization1Marian L. Neuhouserperson1
Recent coverage
  • HEALTHJun 30 · 20:47 UTCWTOP DC
    Can GLP-1s Treat Cancer? What the Latest Science Says About Ozempic’s Newest Benefit

    GLP-1 receptor agonists, including Ozempic, show potential in reducing cancer risk through weight loss, inflammation reduction, and metabolic improvements. Early studies link their use to a 30-35% lower breast cancer incidence in women and reduced risks for colorectal, endometrial, ovarian, liver, and brain cancers.

Rahul Gosain · Dossier · The Nexus